Applied DNA Sciences Inc logo

APDN - Applied DNA Sciences Inc Share Price

$8.95 -0.7  -7.6%

Last Trade - 26/02/21

Sector
Basic Materials
Size
Micro Cap
Market Cap £48.0m
Enterprise Value £45.6m
Revenue £2.09m
Position in Universe 5316th / 6715
Bullish
Bearish
Unlock APDN Revenue
Momentum
Relative Strength (%)
1m -18.6%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -45.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
9.01 4.19 4.75 3.90 5.39 1.93 12.4 21.6 -26.5%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 December 2020, AppliedDNA Sciences Inc revenues increased from $634K to $1.6M.Net loss applicable to common stockholders increased 80% to$4.8M. Revenues reflect Service revenues increase from$396K to $1.1M, Product revenues increase from $238K to$550K. Higher net loss reflects Selling, general andadministrative increase of 48% to $3.5M (expense), Researchand development increase of 33% to $748K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

APDN Revenue Unlock APDN Revenue

Net Income

APDN Net Income Unlock APDN Revenue

Normalised EPS

APDN Normalised EPS Unlock APDN Revenue

PE Ratio Range

APDN PE Ratio Range Unlock APDN Revenue

Dividend Yield Range

APDN Dividend Yield Range Unlock APDN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
APDN EPS Forecasts Unlock APDN Revenue
Profile Summary

Applied DNA Sciences, Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company's platform ingredient, at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.

Directors
Last Annual September 30th, 2020
Last Interim December 31st, 2020
Incorporated December 17, 2008
Public Since April 10, 2008
No. of Shareholders: 124
No. of Employees: 59
Sector Basic Materials
Industry Chemicals
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 7,473,074
Free Float (0.0%)
Eligible for
ISAs
SIPPs
APDN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for APDN
Upcoming Events for APDN
Frequently Asked Questions for Applied DNA Sciences Inc
What is the Applied DNA Sciences Inc share price?

As of 26/02/21, shares in Applied DNA Sciences Inc are trading at $8.95, giving the company a market capitalisation of £48.0m. This share price information is delayed by 15 minutes.

How has the Applied DNA Sciences Inc share price performed this year?

Shares in Applied DNA Sciences Inc are currently trading at $8.95 and the price has moved by 0.118k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Applied DNA Sciences Inc price has moved by 68.41% over the past year.

What are the analyst and broker recommendations for Applied DNA Sciences Inc?

Of the analysts with advisory recommendations for Applied DNA Sciences Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Applied DNA Sciences Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Applied DNA Sciences Inc next release its financial results?

Applied DNA Sciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Applied DNA Sciences Inc dividend yield?

Applied DNA Sciences Inc does not currently pay a dividend.

Does Applied DNA Sciences Inc pay a dividend?

Applied DNA Sciences Inc does not currently pay a dividend.

When does Applied DNA Sciences Inc next pay dividends?

Applied DNA Sciences Inc does not currently pay a dividend.

How do I buy Applied DNA Sciences Inc shares?

To buy shares in Applied DNA Sciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Applied DNA Sciences Inc?

Shares in Applied DNA Sciences Inc are currently trading at $8.95, giving the company a market capitalisation of £48.0m.

Where are Applied DNA Sciences Inc shares listed? Where are Applied DNA Sciences Inc shares listed?

Here are the trading details for Applied DNA Sciences Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: APDN
What kind of share is Applied DNA Sciences Inc?

Based on an overall assessment of its quality, value and momentum, Applied DNA Sciences Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Applied DNA Sciences Inc share price forecast 2021?

Shares in Applied DNA Sciences Inc are currently priced at $8.95. At that level they are trading at 0.109% discount to the analyst consensus target price of 0.00.

Analysts covering Applied DNA Sciences Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.117 for the next financial year.

How can I tell whether the Applied DNA Sciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Applied DNA Sciences Inc. Over the past six months, the relative strength of its shares against the market has been 7.08%. At the current price of $8.95, shares in Applied DNA Sciences Inc are trading at 5.88% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Applied DNA Sciences Inc PE Ratio?

We were not able to find PE ratio data for Applied DNA Sciences Inc.

Who are the key directors of Applied DNA Sciences Inc?

Applied DNA Sciences Inc's management team is headed by:

James Hayward - CHM
Ming-Hwa Liang - SEC
John Bitzer - IND
Judith Murrah - COO
Joseph Ceccoli - IND
Beth Jantzen - CFO
Robert Catell - DRC
Elizabeth Ferguson - DRC
Scott Anchin - IND
Who are the major shareholders of Applied DNA Sciences Inc?

Here are the top five shareholders of Applied DNA Sciences Inc based on the size of their shareholding:

Empery Asset Management, L.P. Investment Advisor/Hedge Fund
Percentage owned: 6.42% (480k shares)
Montgomery (William W) Individual Investor
Percentage owned: 6.23% (466k shares)
Heights Capital Management, Inc. Investment Advisor
Percentage owned: 6.09% (455k shares)
Dillon Hill Capital, LLC Investment Advisor
Percentage owned: 3.81% (285k shares)
Hedgehog Capital, L.L.C. Hedge Fund
Percentage owned: 3.35% (250k shares)
Similar to APDN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.